Meisel C, Schefold JC et al. GM-CSF to reverse sepsis-associated immunosuppression: a double-blind randomized placebo-controlled multicenter trial. In: Carbone, G. Fabbrocini, D. Spiteri, M. Montella: HHV-8 prevalence, immunosuppression and Kaposi’s sarcoma in South Italy; Int J Mol Med. 7. Mai 2001; S A re-evaluation of the role of macrophages in carrageenan-induced immunosuppression. In: Immunology, 1977 September, 33(3), S. 423–432, PMC 1445637 (freier korrespondierendes Mitglied der Akademie der Wissenschaften der DDR an. Chemical Immunosuppression. Barth, Leipzig 1975 Immunopathology of Viral Diseases. VEB Gustav 2010 Jan;62(1):9-21. R. Ader, N. Cohen: Behaviorally conditioned immunosuppression. In: Psychosomatic medicine. Band 37, Nummer 4, 1975, S. 333–340, 2014 (3Sat-Mediathek) R. Ader, N. Cohen: Behaviorally conditioned immunosuppression. In: Psychosomatic medicine. Band 37, Nummer 4, 1975, S. 333–340, Michael S. (2005) New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated Medizinlexikon - Urocaninsäure Schwarz T: Mechanisms of UV-induced immunosuppression. Keio J Med 2005;54(4):165-171. Egawa M, Nomura J, Iwaki H: The evaluation Budde, M. Giessing, L. Liefeldt, H.H. Neumayer, P. Glander: Modern immunosuppression following renal transplantation. Standard or tailor made? In: Urologe K. Krämer, Hans J. Schlitt: Current concepts and perspectives of immunosuppression in organ transplantation. In: Langenbeck's Archives of Surgery Band J. C. Lehmann, J. J. Listopad u. a.: Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase Risler, H Bockhorn: Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine. In: Transplant Am J Transplant 2010; 10: 1401; PMID 20455882 dailymed: WARNING: IMMUNOSUPPRESSION AND RENAL FUNCTION, April 2010. Campistol JM. et al.. Everolimus Society for Surgical Research (ESSR) in Salzburg für die Arbeit: „Immunosuppression by donor-specific bone marrow transplantation and low dosecyclosporine Clausen, T. Schwarz: Langerhans cells are required for UVR-induced immunosuppression. In: J Invest Dermatol., 2010 May, 130(5), S. 1419–1427 Clinical multiple immune subsets and induces phenotypic alterations suggestive of immunosuppression. In: PLoS ONE. Band 7, Nummer 12, 2012, S. e49897, doi:10.1371/journal Clausen BE, Schwarz T. "Langerhans cells are required for UVR-induced immunosuppression" J Invest Dermatol. 2010 May;130(5):1419-27 Stellungnahme der AG ISBN 0-674-66984-3. R. Ader und N. Cohen: Behaviorally conditioned immunosuppression. In: Psychosom Med. 37, 1975, S. 333–340. PMID 1162023. T. Donner-Wielke in der Diabetes-Therapie:Transplantation of human islets without immunosuppression Inselzelltransplantation am Universitätsklinikum Carl Gustav Carus R. A. Good: Successful tissue and organ transplantation without immunosuppression. J. Clin. Ivest. Band 52, 1973, S. 34a. NIH to review Emory in Darsee Nephrol 22, 2009, S. 326–332. PMID 19557709 (Review) S. Chadban u. a.: Immunosuppression in renal transplantation: some aspects for the modern era. In: Transplant Kur F, et al.: Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation. In: Transplantation 0b013e318184ca6a H. Madania, S. Hettiaratchyb, A. Clarkea, P.E.M. Butlera: Immunosuppression in an emerging field of plastic reconstructive surgery: composite 2005;165:416-423. Pezzotti P et al: Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the Clausen, T. Schwarz: Langerhans cells are required for UVR-induced immunosuppression. In: J Invest Dermatol. 2010 May; 130(5), S. 1419–1427. T. Ruzicka